QA: Regulus Therapeutics Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2015_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 164,951,000
1 IntangibleAssetsNetIncludingGoodwill 1,150,000
2 PropertyPlantAndEquipmentNet 3,568,000
3 remainder_Assets 1,811,000
4 LiabilitiesCurrent 35,192,000
5 LiabilitiesNoncurrent 1,022,000
6 remainder_Liabilities 3,252,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,533,000
9 ResearchAndDevelopmentExpense 41,046,000
10 remainder_Expenses 40,000
11 remainder_Revenues 8,057,000
12 remainder_NetIncome -12,118,000
13 remainder_ComprehensiveNetIncome -181,000
  yvar yval
0 Assets 171,480,000
1 Liabilities 39,466,000
2 Expenses 52,619,000
3 Revenues 8,057,000
4 StockholdersEquity 132,014,000
5 NetIncome -56,680,000
6 ComprehensiveNetIncome -56,770,500
7 BaseVar 141,960,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.19
9 EconomicCapitalRatio 3.15

Edgar->Model Mapping

Feature Distribution

Change over Time